Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX^® Modified Release Tablets in Healthy Male and Female Volunteers

• Main Authors: Andrea Francesco Daniele Di Stefano (Author), Milko Massimiliano Radicioni (Author), Angelo Vaccani (Author), Alessandro Mazzetti (Author), Luigi Maria Longo (Author), Luigi Moro (Author)
• Format: Book
• Published: MDPI AG, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV's pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release tablets containing 600 mg of the oral non-absorb...